Dow Jones

38 798,99

-0,22%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Locust Walk Acquisition Corporation (LWAC)
Locust Walk Acquisition Corporation (LWAC) Actualités

LWAC

Locust Walk Acquisition (LWAC)

Locust Walk Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:LWAC

Date	Heure	Source	Titre	Symbole	Société
27/06/2023	12h04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
23/06/2023	22h02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
08/06/2023	12h15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
08/06/2023	12h07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
16/05/2023	14h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
12/05/2023	22h24	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
12/05/2023	22h19	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
12/05/2023	22h13	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
09/05/2023	22h23	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
08/03/2023	22h17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
07/03/2023	23h26	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
14/02/2023	12h35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
28/09/2022	22h43	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
11/08/2022	22h56	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
18/03/2022	11h05	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
25/01/2022	22h32	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
17/12/2021	22h32	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
01/10/2021	23h14	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
03/09/2021	22h01	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
26/08/2021	01h18	GlobeNewswire Inc.	eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer Therapies	NASDAQ:LWAC	Locust Walk Acquisition Corporation
24/08/2021	22h47	GlobeNewswire Inc.	Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies	NASDAQ:LWAC	Locust Walk Acquisition Corporation
23/08/2021	14h58	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
09/08/2021	23h28	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:LWAC	Locust Walk Acquisition Corporation
22/07/2021	14h00	GlobeNewswire Inc.	eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral Agent	NASDAQ:LWAC	Locust Walk Acquisition Corporation
16/07/2021	14h00	GlobeNewswire Inc.	eFFECTOR Therapeutics Announces Publication of Tomivosertib Preclinical Data in Cell Reports	NASDAQ:LWAC	Locust Walk Acquisition Corporation
03/06/2021	22h15	GlobeNewswire Inc.	Locust Walk Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report ...	NASDAQ:LWAC	Locust Walk Acquisition Corporation
27/05/2021	14h00	GlobeNewswire Inc.	eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation ...	NASDAQ:LWAC	Locust Walk Acquisition Corporation